Predicting the ergogenic response to methylphenidate.

Journal: European journal of applied physiology

Volume: 118

Issue: 4

Year of Publication: 2018

Affiliated Institutions:  Division of Exercise Science and Sports Medicine, University of Cape Town, Cape Town, South Africa. michaeltcking@me.com. Division of Exercise Science and Sports Medicine, University of Cape Town, Cape Town, South Africa. Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa. Vascular Neurology and Neurorehabilitation, University of Zurich, Zurich, Switzerland.

Abstract summary 

Methylphenidate (MPH) and other stimulants have been shown to enhance physical performance. However, stimulant research has almost exclusively been conducted in young, active persons with a normal BMI, and may not generalize to other groups. The purpose of this study was to determine whether the ergogenic response to MPH could be predicted by individual level characteristics.We investigated whether weekly minutes of moderate-to-vigorous physical activity (MVPA), age, and BMI could predict the ergogenic response to MPH. In a double-blind, cross-over design 29 subjects (14M, 15F, 29.7 ± 9.68 years, BMI: 26.1 ± 6.82, MVPA: 568.8 ± 705.6 min) ingested MPH or placebo before performing a handgrip task. Percent change in mean force between placebo and MPH conditions was used to evaluate the extent of the ergogenic response.Mean force was significantly higher in MPH conditions [6.39% increase, T(25) = 3.09, p = 0.005 118.8 ± 37.96 (± SD) vs. 111.8 ± 34.99 Ns] but variable (coefficient of variation:163%). Using linear regression, we observed that min MVPA (T(25) = -2.15, β = -0.400, p = 0.044) and age [T(25) = -3.29, β = -0.598, p = 0.003] but not BMI [T(25) = 1.67, β = 0.320 p = 0.109] significantly predicted percent change in mean force in MPH conditions.We report that lower levels of physical activity and younger age predict an improved ergogenic response to MPH and that this may be explained by differences in dopaminergic function. This study illustrates that the ergogenic response to MPH is partly dependent on individual differences such as habitual levels of physical activity and age.

Authors & Co-authors:  King Michael M Van Breda Keelyn K Stein Dan J DJ Lutz Kai K Rauch H G Laurie HGL

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  5
Identifiers
Doi : 10.1007/s00421-018-3800-8
SSN : 1439-6327
Study Population
Male,Female
Mesh Terms
Adult
Other Terms
Athletic doping;Athletic performance;Ergogenic stimulants;Ritalin
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
Germany